United States Lab Automation Market 2026 | Growth Drivers, Key Players & Investment Opportunities

Market Size and Growth

The growing need for faster research outcomes, accurate diagnostics, and high-throughput laboratory operations is accelerating the adoption of automation technologies worldwide. Laboratories across healthcare, pharmaceutical, and biotechnology sectors are increasingly implementing automated systems to enhance productivity, minimize human error, and streamline complex experimental workflows. According to DataM Intelligence, Global Lab Automation Market size is USD 9.04 billion in 2025 and is projected to reach USD 18.39 billion by 2033, growing at a CAGR of 9.3% from 2026 to 2033.

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://www.datamintelligence.com/download-sample/lab-automation-market?sb

Key Development:

United States: Recent Industry Developments

✅ In March 2026, Lila Sciences expanded its automated "AI science factory" laboratory platform in Cambridge, integrating robotics, AI models, and automated experimentation systems. The facility enables continuous experimentation and rapid scientific discovery. The initiative strengthens automated research infrastructure for pharmaceuticals, materials science, and energy innovation.

✅ In February 2026, Roche Diagnostics enhanced its cobas laboratory automation portfolio with AI-driven predictive maintenance and advanced sample tracking technologies. The upgrade improves workflow optimization and reduces laboratory downtime. It supports high-throughput diagnostic laboratories handling large testing volumes.

✅ In January 2026, Dash Bio secured additional funding to expand its robotic laboratory automation platform for automated drug testing and sample analysis. The system combines robotics and software to accelerate clinical research workflows. The investment strengthens automation adoption in pharmaceutical R&D laboratories.

✅ In December 2025, Eli Lilly announced plans to build a new pharmaceutical manufacturing and research facility in Alabama incorporating advanced laboratory automation and digital technologies. The facility will support automated drug development and production processes. The investment aims to strengthen U.S. pharmaceutical research and manufacturing capabilities.

Buy Now & Unlock 360° Market Intelligence: https://www.datamintelligence.com/buy-now-page?report=lab-automation-market

Japan: Recent Industry Developments

✅ In March 2026, Japanese research institutions accelerated the deployment of automated laboratory systems integrating robotics and digital interfaces for high-throughput diagnostic and research workflows. These systems improve experimental reproducibility and reduce manual handling errors. The initiative supports Japan's modernization of clinical and pharmaceutical laboratories.

✅ In February 2026, the Japanese government launched a biotechnology strategy initiative encouraging public-private investment in advanced research infrastructure, including automated laboratory platforms. The program focuses on accelerating innovation in synthetic biology, pharmaceuticals, and biomanufacturing. It aims to strengthen Japan's life-science research ecosystem.

✅ In January 2026, several Japanese clinical laboratories expanded the use of automated centrifugation and digital monitoring systems to streamline sample processing and data management. The technology integrates sensors and programmable workflows to improve laboratory efficiency. It supports large-scale diagnostic testing and research operations.

✅ In October 2025, Astellas Pharma and Yaskawa Electric established a joint venture focused on robotics-driven cell therapy manufacturing and automated laboratory processes. The collaboration integrates robotics and AI to improve cell cultivation and regenerative medicine research. The initiative advances automation adoption in Japan's biotechnology sector.

Speak to Our Analyst and Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/lab-automation-market?sb

Increasing Demand from Pharmaceutical and Biotechnology Research
One of the key factors driving the growth of the lab automation market is the rapid expansion of pharmaceutical and biotechnology research activities. Drug discovery and development processes require the handling of thousands of samples and complex experimental procedures. Automation technologies help laboratories perform these processes more efficiently while ensuring reliable and reproducible results.

Automated liquid handling platforms, robotic sample storage systems, and integrated laboratory software are widely used to improve workflow efficiency in pharmaceutical research. These technologies allow researchers to conduct high-throughput screening, compound testing, and sample preparation with greater accuracy and speed.

As investments in biologics, personalized medicine, and advanced therapeutics continue to grow, pharmaceutical companies are increasingly adopting automated laboratory systems to support the complexity and scale of modern drug development programs.

Competitive Landscape and Industry Participants
The lab automation market is highly competitive, with several established technology providers offering a wide range of automated laboratory solutions. Prominent companies operating in this market include: Thermo Fischer Scientific, Tecan Group, Siemens Health Care, Roche Holding AG, Qiagen NV, Perklinelmer Inc., Hamilton Robotics Inc., Agilent Technologies, and Beckman Coulter Inc.

Key Segments:

By Product Type

Automated Liquid Handling Systems lead the market with 38% share, driven by increasing demand for high-throughput screening, precise sample handling, and workflow automation in pharmaceutical and biotechnology laboratories. Microplate Readers hold 32%, supported by their extensive use in drug discovery, diagnostics, and life science research for analyzing biochemical reactions. Automated Storage and Retrieval Systems account for 20%, fueled by the need for efficient sample storage, inventory management, and retrieval in large-scale laboratories. Others contribute 10%, reflecting emerging laboratory automation tools and integrated robotic systems.

By Application

Drug Discovery dominates with 35% share, driven by increasing pharmaceutical R&D investments and the growing need for automated systems to accelerate drug development processes. Clinical Diagnostics holds 25%, supported by rising demand for rapid and accurate diagnostic testing in clinical laboratories. Genomics Solutions account for 22%, fueled by growing adoption of sequencing technologies and precision medicine research. Clinical Discovery represents 18%, reflecting increasing research activities focused on identifying new therapeutic targets and biomarkers.

By End-User

Pharma and Biotech Companies lead with 65% share, driven by extensive research and development activities, high-throughput screening needs, and adoption of automation technologies to improve efficiency and reduce operational costs. Diagnostic Laboratories hold 35%, supported by increasing diagnostic testing volumes and the need for reliable automated laboratory workflows.

By Region

North America leads the market with 34% share, supported by strong pharmaceutical and biotechnology industries, advanced research infrastructure, and high adoption of laboratory automation technologies. Europe holds 27%, driven by growing research initiatives, biotechnology innovation, and increasing healthcare investments. Asia Pacific accounts for 24%, fueled by rapid expansion of pharmaceutical manufacturing, biotechnology research, and government support for life sciences innovation. Latin America represents 8%, reflecting growing adoption of advanced diagnostic technologies. Middle East & Africa hold 7%, supported by improving healthcare infrastructure and increasing investment in clinical research.

Outlook & Opportunity Analysis (2026-2033)

The global laboratory automation and sample management market is expected to witness strong growth from 2026 to 2033, driven by rising demand for high-throughput research, increasing pharmaceutical R&D activities, and the need for efficient sample processing and storage solutions. Automated liquid handling systems and microplate readers will continue to dominate due to their critical role in drug discovery and clinical diagnostics. Pharma and biotech companies will remain the largest end-users, while diagnostic laboratories are expected to see increasing adoption as testing volumes grow. Asia Pacific is projected to experience the fastest growth due to expanding biotechnology sectors, increasing research investments, and rising adoption of laboratory automation technologies. Advances in robotic automation, AI-driven laboratory systems, and integrated sample management platforms will further create new opportunities for innovation and efficiency across life sciences research and diagnostics.

Unlock 360° Market Intelligence with DataM Subscription Services: https://www.datamintelligence.com/reports-subscription

Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.

✅ Competitive Landscape
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Unmet Needs & Positioning, Pricing & Market Access Snapshots
✅ Market Volatility & Emerging Risks Analysis
✅ Quarterly Industry Report Updated
✅ Live Market & Pricing Trends
✅ Import-Export Data Monitoring

Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us -

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -

DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.